Evoke Pharma
EVOK
EVOK was delisted on the 16th of December, 2025.
19 hedge funds and large institutions have $4.96M invested in Evoke Pharma in 2020 Q2 according to their latest regulatory filings, with 4 funds opening new positions, 6 increasing their positions, 1 reducing their positions, and 3 closing their positions.
500% more repeat investments, than reductions
Existing positions increased: 6 | Existing positions reduced: 1
192% more capital invested
Capital invested by funds: $1.7M → $4.96M (+$3.26M)
33% more first-time investments, than exits
New positions opened: 4 | Existing positions closed: 3
6% more funds holding
Funds holding: 18 → 19 (+1)
0% less ownership
Funds ownership: 0.04% → 0.04% (-0%)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Vanguard Group
Malvern,
Pennsylvania
|
+$337K |
| 2 |
BlackRock
New York
|
+$268K |
| 3 |
Goldman Sachs
New York
|
+$67.9K |
| 4 |
Morgan Stanley
New York
|
+$50.3K |
| 5 |
Acadian Asset Management
Boston,
Massachusetts
|
+$12K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
SOMRS
State of Michigan Retirement System
Lansing,
Michigan
|
-$464K |
| 2 |
Citadel Advisors
Miami,
Florida
|
-$31K |
| 3 |
Geode Capital Management
Boston,
Massachusetts
|
-$30K |
| 4 |
Victory Capital Management
San Antonio,
Texas
|
-$8K |
EVOK Hedge Fund Activity: Q2 2020 in Review
19 of the 4,878 institutional investors tracked by Wall St. Rank reported a position in Evoke Pharma (EVOK) for Q2 2020, worth a combined $4.96M — up 192% from $1.7M a quarter earlier.
Buyers outnumbered sellers: 4 funds opened new EVOK positions and 3 closed out — a net gain of 1 holder — while 6 added to existing stakes and 1 trimmed.
The largest buyer was Vanguard Group, adding an estimated $337K. The largest seller was State of Michigan Retirement System, exiting entirely with an estimated $464K sold.
- 19 institutional investors held Evoke Pharma (EVOK) as of Q2 2020, up from 18 in Q1 2020.
- Funds reported $4.96M of Evoke Pharma stock for Q2 2020, up 192% quarter-over-quarter.
- 4 funds opened new Evoke Pharma positions in Q2 2020 and 3 closed out, a net change of +1 holder.
- The largest Evoke Pharma buyer in Q2 2020 was Vanguard Group, an estimated $337K added.
- The largest Evoke Pharma seller in Q2 2020 was State of Michigan Retirement System, an estimated $464K sold.
Based on aggregated 13F filings for Q2 2020.